Reporter

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

A switch for autoimmunity

Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies.

Major makeover set to expand My Health at Vanderbilt features

My Health at Vanderbilt (MHAV) is an online software application that lets patients interact with their electronic medical records, communicate securely with their health care team and pay medical bills electronically.

Researcher targets peanut allergies with Cohen Fund support

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith’s research could fundamentally change allergy treatment.

Vanderbilt physicians lauded by Best Doctors in America

Best Doctors in America, a biennial listing of the nation’s physicians who are peer selected for inclusion, is once again acknowledging the expertise of Vanderbilt University Medical Center’s (VUMC) faculty.

Award honors Conn’s mental health research contributions

P. Jeffrey Conn, Ph.D., founding director of the Vanderbilt Center for Neuroscience Drug Discovery, has won a 2017 Research & Hope Award from the Pharmaceutical Research and Manufacturers of America (PhRMA) for outstanding research in the area of mental health.

1 335 336 337 338 339 725